What You Should Know:
- Opmed.ai, the AI optimization platform for healthcare, announced today the successful raise of $15M in series A funding.
- The round was co-led by NFX and Grove Ventures, with Secret Chord Ventures, the Impact investor Sir Ronald Cohen, and Unbox Ventures also
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Exploring The Impact of AR in Surgical Training and Simulation
Human surgery training has used the classical approach of dissections of bodies and presence in live surgery for a long time. These means offer truly priceless opportunities to learn but multiple problems lie in accessibility, interactivity, and safety. AR has started a new era in surgical training through its affordability, interactivity, and safety. However, there still exists a need for proof regarding its effectiveness and the possibility of any negative effects. In this article, we
Read More
Otsuka Precision Health Launches: Personalized Care Powered by AI and Digital Solutions
What You Should Know:
- Otsuka America, Inc. (OAI) today announced the formation of Otsuka Precision Health (OPH), a new subsidiary dedicated to transforming patient care through innovative digital solutions and a data-driven approach.
- OPH will leverage cutting-edge technology, including artificial intelligence (AI) and digital therapeutics, to personalize patient care journeys across various conditions, from mental health to nephrology.
A Patient-Centric Approach Powered by
Read More
FemTech: Nuvo Goes Public to Expand Remote Pregnancy Monitoring
What You Should Know:
- Nuvo Group D.G. Ltd. (NASDAQ: NUVO) ("Nuvo"), a leader in remote pregnancy monitoring, today announced the successful completion of its business combination with LAMF Global Ventures Corp. I (NASDAQ: LGVC, LGVCU, LGVCW) ("LAMF"), a publicly traded special purpose acquisition company (SPAC).
- As part of the business combination, Nuvo will retain its name and existing management team, trading on the NASDAQ under the ticker symbol "NUVO" starting May 2nd,
Read More
NVIDIA Makes Drug Discovery, Medical Imaging, and Genomics Easier with Cloud-Based AI
What You Should Know:
- Harnessing the power of AI for healthcare just got simpler. NVIDIA announced the integration of NVIDIA NIM, a collection of cloud-native AI microservices, with Amazon Web Services (AWS).
- The strategic collaboration empowers developers to leverage pre-trained AI models for drug discovery, medical imaging analysis, and genomics research – all accessible through user-friendly APIs.
Streamlined Access to Powerful AI Tools
NIM integrates seamlessly with
Read More
Large Language Models Show Promise for Streamlining Physician Workflows, But Safety Concerns Remain
What You Should Know:
- A new study by researchers at Mass General Brigham suggests large language models (LLMs), a type of artificial intelligence (AI), could be a helpful tool for doctors to streamline communication with patients. However, the study also highlights the importance of human oversight to ensure patient safety.
- The findings, published in The Lancet Digital Health, emphasize the need for a measured approach to LLM implementation.
The Burden of Physician
Read More
Thyme Care Launches Virtual Palliative Care Program to Enhance Cancer Care
What You Should Know:
- Thyme Care, the leading value-based cancer care enabler, today announced Julia Frydman, MD as the company's first medical director for palliative care.
- An academic researcher and former assistant professor from a leading health system renowned for its palliative care and geriatrics department, Dr. Frydman
Read More
WeightWatchers for Business Integrate with Personify Health to Offer Comprehensive Weight Management Solutions
What You Should Know:
- WeightWatchers (NASDAQ: WW), (“WeightWatchers,” “WW,” or the “Company”) today announced that WeightWatchers for Business is partnering with Personify Health (formerly Virgin Pulse) to support employers looking to provide weight health care solutions for their populations.
- Now, organizations using the
Read More
Every Cure and BioPhy Partner to Repurpose Existing Drugs Faster with AI
What You Should Know:
- BioPhy, an AI drug development company, and Every Cure, a non-profit dedicated to unlocking the potential of existing drugs for new uses, today announced a strategic partnership to revolutionize drug repurposing through artificial intelligence (AI).
- The partnership follows Every Cure's recent funding from the Advanced Research Projects Agency for Health (ARPA-H). A successful pilot using AI led to the identification of potential treatments for diseases like sickle
Read More
Transcarent Secures $126M to Expand Employer-Sponsored Healthcare
What You Should Know:
- Transcarent, a platform simplifying health and care for employers and individuals, secures $126 million in a Series D funding round led by General Catalyst and 7wireVentures.
- The latest funding brings Transcarent's total funding to approximately $450M at a valuation of $2.2B.
A One-Stop Solution for Employer-Sponsored Healthcare
Transcarent's industry-leading platform streamlines healthcare access for both employers and employees. It is the only
Read More
